Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Membranous glomerulopathy and treatment with Acthar®: a case study.

Watson MJ.

Int J Nephrol Renovasc Dis. 2013 Oct 21;6:229-32. doi: 10.2147/IJNRD.S50660. eCollection 2013.

2.

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.

Hladunewich MA, Cattran D, Beck LH, Odutayo A, Sethi S, Ayalon R, Leung N, Reich H, Fervenza FC.

Nephrol Dial Transplant. 2014 Aug;29(8):1570-7. doi: 10.1093/ndt/gfu069. Epub 2014 Apr 8.

3.

Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.

Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.

BMC Nephrol. 2016 Mar 31;17:37. doi: 10.1186/s12882-016-0241-7.

4.

Idiopathic membranous nephropathy: diagnosis and treatment.

Fervenza FC, Sethi S, Specks U.

Clin J Am Soc Nephrol. 2008 May;3(3):905-19. doi: 10.2215/CJN.04321007. Epub 2008 Jan 30.

5.

[Case of MMF monotherapy for membranous nephropathy].

Kobayashi M, Kojima C, Sugiura H, Aoki A, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K.

Nihon Jinzo Gakkai Shi. 2010;52(5):572-7. Japanese.

PMID:
20715589
6.

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group.

Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12.

PMID:
26087670
7.

Nephrotic syndrome and idiopathic membranous nephropathy associated with autosomal-dominant polycystic kidney disease.

Peces R, Martínez-Ara J, Peces C, Picazo M, Cuesta-López E, Vega C, Azorín S, Selgas R.

ScientificWorldJournal. 2011 May 5;11:1041-7. doi: 10.1100/tsw.2011.94.

8.

Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.

Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.

Scand J Urol Nephrol. 2010 Sep;44(4):251-6. doi: 10.3109/00365591003667351.

PMID:
20201749
9.

Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus.

Ahmed MS, Hou SH, Battaglia MC, Picken MM, Leehey DJ.

Am J Kidney Dis. 2007 Dec;50(6):1028-32.

PMID:
18037104
10.
11.

Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.

Rauen T, Michaelis A, Floege J, Mertens PR.

Clin Nephrol. 2009 Jun;71(6):637-42.

PMID:
19473632
12.
13.

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.

Cochrane Database Syst Rev. 2014 Oct 16;(10):CD004293. doi: 10.1002/14651858.CD004293.pub3. Review.

PMID:
25318831
14.

Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.

Sahin GM, Sahin S, Kantarci G, Ergin H.

Nephrology (Carlton). 2007 Jun;12(3):285-8.

PMID:
17498124
15.

Overview of current and alternative therapies for idiopathic membranous nephropathy.

Tran TH, J Hughes G, Greenfeld C, Pham JT.

Pharmacotherapy. 2015 Apr;35(4):396-411. doi: 10.1002/phar.1575. Review.

PMID:
25884528
16.

Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.

Takada D, Mii A, Higo S, Obara Y, Kurabayashi Y, Kurosawa N, Miura S, Kawachi H, Shimizu A.

CEN Case Rep. 2012 May;1(1):16-23. doi: 10.1007/s13730-012-0006-5. Epub 2012 Apr 25.

17.

ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.

Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.

Am J Kidney Dis. 2000 Mar;35(3):381-91.

PMID:
10692263
18.

Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.

Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.

J Hypertens. 2005 Apr;23(4):861-5.

PMID:
15775792
19.

[Membranous nephropathy].

Mercadal L.

Nephrol Ther. 2013 Dec;9(7):507-17. doi: 10.1016/j.nephro.2013.10.002. Epub 2013 Nov 9. French.

PMID:
24315535
20.

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

du Buf-Vereijken PW, Branten AJ, Wetzels JF.

Am J Kidney Dis. 2005 Dec;46(6):1012-29. Review.

PMID:
16310567

Supplemental Content

Support Center